RGX-202 program for Duchenne muscular dystrophy advancing rapidly, topline results expected early Q2 2026 and BLA submission mid-2026 Pivotal trial ...
A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...
In the world of biomedical innovation, few stories embody the spirit of perseverance, intuition, and collaboration quite like ...
Trial Superiority Testing -- Statistical analysis plan allows for hierarchical testing of superiority after non-inferiority ...
The Healthy @Reader's Digest on MSN
“What I Wish I’d Known About Cataract Surgery”: A Doctor Details What Patients Should Know About a Common Procedure
What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” ...
The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...
11h
Diabetes and eye sight: Ophthalmologist reveals the unseen link between diabetes and fading vision
With nearly 90 million Indians living with diabetes, the country is facing a rising crisis of avoidable blindness. Diabetes ...
Central macular thickness and foveal avascular zone enlargement may serve as biomarkers for early diabetic retinopathy progression.
TipRanks on MSN
EyePoint Pharma Advances DURAVYU in Retinal Disease Trials
Eyepoint Pharma ( ($EYPT) ) has released its Q3 earnings. Here is a breakdown of the information Eyepoint Pharma presented to its investors.
Baptist Health Corbin brought back its Diabetes Symposium this past Friday for the first time since the COVID-19 pandemic, ...
Men with diabetes are at a greater risk for developing health complications than women, including problems with their feet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback